Navigation Links
Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections
Date:9/6/2010

create an environment in which microbes are awash in antibiotics, which speeds the process of resistance, he says.

"Right now, pharmaceutical companies are rewarded for actions that conflict with the public health goal of reducing antibiotic resistance," Outterson says. "That has to stop."

The analysis in Health Affairs crafts an innovative solution to the problem, one that gives pharmaceutical companies financial incentives to market drugs in a way that would keep resistance rates at low levels.

Specifically, Kesselheim and Outterson suggest that government experts study the rates of resistance and set "effectiveness targets" for newly approved antibiotics. To meet those goals, which the authors say would be based on factors related to the disease targeted by the antibiotic, such as lower resistance rates, drug companies would need to coordinate with physicians and hospitals so that the drugs are prescribed only when clinically indicated. Such action would remove the current incentive to oversell.

Companies that met the predetermined targets (achieved through responsible use of the drugs) would be rewarded. For example, the authors suggest that Medicare could pay a bonus to companies producing drugs that meet their resistance targets. Or policy-makers could grant such companies extended market exclusivity so they could continue to earn revenuesas long as the drug use remained within the target zone.

Such a policy could help slow development of resistance in microbes and ensure new antibiotics have a longer shelf life, a bonus that would help not just individual patients but society as a whole, Kesselheim and Outterson predict.

The authors, and other experts, say that the United States must adopt more comprehensive strategies that give drug companies and others incentives to reduce antibiotic resistance. For example, hospitals should be financially rewarded for adhering to strict infection-control practic
'/>"/>

Contact: Becky Wexler
bwexler@burnesscommunications.com
301-652-1558
Burness Communications
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Pharmaceuticals: A market for producing lemons and serious harm
2. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
3. The malicious use of pharmaceuticals: An under-recognized form of child abuse
4. Mary Hendrickson of GENCO Pharmaceutical Services Speaks Before Senate on the Topic of Drug Take-Back Programs
5. SDI Reports: Novo Nordisk Takes Top Ranking Among Endocrinologists, According To Pharmaceutical Company Image Study
6. Chinese Biopharmaceutical Association Successfully Holds 15th Annual Conference
7. Omega Design Presented Pharmaceutical Packaging Solutions at the Healthcare Packaging Conference & Workshop 2010
8. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
9. Pharmaceutical companies provide EPA 100 drugs to help predict toxicity
10. HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings
11. SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 The popular ... of their new L-Style Revolution™ Program. The customized program ... and women of all health and fitness levels to ... goals faster than traditional methods. , “We’re really proud ... customized plans based on award winning techniques to help ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is ... joined the company as Chief Technology Officer. Mr. Dvorak ... the company, including customer-centric strategies and initiatives, and promoting ... experience as a technology executive and visionary. Prior to ... FBI including oversight of enterprise data management, analytic software ...
(Date:3/4/2015)... New Port Richey, FL (PRWEB) March 04, 2015 ... Novus Medical Detox cut the ribbon on their new facility ... West Pasco Chamber of Commerce. The new facility will allow ... mission of helping end the prescription drug abuse epidemic through ... the current reality of drug addiction in the United States, ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 ... have been selected by Chase Brexton Health Care, ... announced today. , Chase Brexton provides comprehensive primary ... than 30,000 patients across seven clinics in the ... adopters of electronic medical records, the organization has ...
(Date:3/4/2015)... Dietary supplement company MitoSynergy will showcase ... chelate, at Natural Products Expo West 2015 at booth ... insight into their wellness through a free ZYTO scan ... their individual nutritional needs, all while relaxing in a ... of the MitoSynergy product line, was developed to provide ...
Breaking Medicine News(10 mins):Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2
... Charity Event to benefit Breast Cancer ResearchFORT LAUDERDALE, Fla., ... are invited to join Ladies Sail for a Cure, ... to raise money for the Florida Breast Cancer Coalition ... charity sailing event organized by eBoatCharters.com. The sailing catamaran, ...
... Your animal buddy can,t read it. Your vet may not read it. But you ... That,s the reason Jim Schwartz wrote the book:, , ... to stop harmful over-vaccination of our pets; , ... your animal companion; , to describe an insurance ...
... BEACH, Calif., Jan. 22 Forterus Healthcare, a division ... that it has acquired Solutions 4 Recovery, a Dana ... expected to close Feb. 1 2009Forterus Healthcare will operate ... Forterus, Inc. Solutions 4 Recovery is the second behavioral ...
... to be Presented at This Week,s Keystone Symposium - ... WALTHAM, Mass., Jan. 22 Interleukin Genetics, Inc. (NYSE ... present new research findings on the role genetics play ... fat while following a calorie-restricted diet, during tomorrow,s Keystone ...
... Hospital for Children has achieved Magnet designation for excellence ... (ANCC) Magnet Recognition Program(R). Magnet recognition is one ... medical center can achieve. "The Magnet recognition is ... but it doesn,t change who we are," says Karen ...
... - at the Pravasi Bharatiya Divas convention in Chennai, January 7-10, ... the world,s first comprehensive health care organization with an emphasis on ... ... Chennai (PRWEB) January 22, 2009 -- At the Pravasi ...
Cached Medicine News:Health News:Ladies Set Sail to Raise Money for a Cure 2Health News:Why Your Pet Wants You to Read 'Trust Me: I'm Not a Veterinarian!': Jim Schwartz's New Book Is a Self-Defense Manual for Animal Guardians 2Health News:Forterus Healthcare to Acquire Solutions 4 Recovery 2Health News:Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss 2Health News:Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss 3Health News:St. Christopher's Hospital for Children Earns National Recognition for Nursing Excellence 2Health News:Doctors of Indian origin unite to tackle global health problems - the creation of The first ever Global Association of Physicians of Indian Origin (GAPIO) 2Health News:Doctors of Indian origin unite to tackle global health problems - the creation of The first ever Global Association of Physicians of Indian Origin (GAPIO) 3
(Date:3/4/2015)... , March 4, 2015   Mallinckrodt ... biopharmaceutical company, will present at the Barclays Global Healthcare ... Miami, Florida , on Wednesday, March 11, 2015. Mark ... represent the company in a session scheduled to begin ... attend the meeting in person can find webcast information ...
(Date:3/4/2015)...   Symbiomix Therapeutics , a late-stage, privately ... women,s health infections, today announced results from its ... product candidate, SYM-1219, was safe and well tolerated ... efficacy for birth control pills would not be ... will be presented on March 6 th ...
(Date:3/3/2015)... -- Actavis plc (NYSE: ACT ) today ... billion aggregate principal amount of senior unsecured notes in ... issued by its indirect wholly-owned subsidiary, Actavis Funding SCS, ... "Notes"), as follows: Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... $500,000,000 , Due 2016 , 100.00% 1.850% ...
Breaking Medicine Technology:Mallinckrodt to Present at Barclays Conference March 11 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10
... 2011 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... and live webcast on Wednesday, November 2, 2011 at 9:00 ... The Company will release its financial results on November 2, ... live webcast can be made via the Company,s website at ...
... 2011 The Infectious Disease Research Institute (IDRI) announces ... broad range of instrumentation and equipment that will assist ... the burden of disease in the developing world. IDRI ... trials in the areas of tuberculosis, leishmaniasis, malaria, leprosy, ...
Cached Medicine Technology:GlaxoSmithKline Donates Scientific Equipment to Advance IDRI's Global Health Mission 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
Medicine Products: